Drug Device Combination Products | Episode 03-Regulatory Procedure:Combination Products in EU Part-1

Welcome to the PharmaCamp with Neha. This is a small initiative from my side to share knowledge about the pharmaceutical world and regulatory, as I feel education is the best gift one can receive or give back to society. Are you a working professional who wants to upgrade your skills? OR a student who wants to make a career in pharmaceuticals? OR are you a person who is interested to learn about the regulatory systems? Then this YouTube channel is for you. About me: I am Neha Parashar, working as a Associate Director in a pharmaceutical company and based in Germany. I am a passionate healthcare professional, an educator, and a mentor. In this series 'Drug Device Combination Products', I will discuss the regulatory aspects related to Combination products. Channel Introduction- Welcome to PharmaCamp    • Welcome to PharmaCamp with Neha | Regulato...   Series 1 -Regulatory Learnings | Investigational New Drug (IND) Application    • Regulatory Learnings | Investigational New...   Series 2-Regulatory Shorts    • Regulatory Shorts   Series 3-EU Marketing Authorisation    • EU Marketing Authorisation   Series 4-Dare to Lead with Neha | An Interview Series with Pharma Leaders    • Dare To Lead - An Interview Series With Ph...   Series 5-Orphan Drug Development    • Orphan Drug Development   LinkedIn:   / neha-parashar   LinkedIn Articles on various Regulatory Topics: 1. Regulatory Pathways for Expedited Access of Medicines   / regula.  . 2. Step-wise Regulatory approach for the Paediatric drug Development   / step-w.  . 3. Designing the Global Regulatory Strategy for the Development of Orphan Medicinal Products   / design.  . 4. Step wise approach for Quality Risk Management (QRM) in pharmaceutical industries   / step-w.  . 5. Step-wise regulatory approach for the assessment of process related impurities in biological products   / step-w.  . 6. Step-wise approach for sterilisation package preparation in regulatory dossiers for biologicals and other liquid sterilised products   / step-w.  . 7. Step-wise approach for regulatory risk assessment of adventitious agents in biologicals products   / step-w.  . 8. Five Step Approach to Assess Equivalency Requirements of Topical Products   / five-s.  . Disclaimer- This video channel is for educational purposes. These are purely my views and not any recommendations. The channel does not represent the views of the organization I am associated with, and it has no connection with my current organization. #CombinationProducts #DrugDevice #RegulatoryProcedure #EURegulations #HealthcareIndustry #Innovation #MedicalDevices #EUCompliance #Pharmaceuticals #MedicalTechnology